Håkan Wallén

5.2k total citations · 1 hit paper
130 papers, 3.7k citations indexed

About

Håkan Wallén is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Immunology. According to data from OpenAlex, Håkan Wallén has authored 130 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 30 papers in Hematology and 26 papers in Immunology. Recurrent topics in Håkan Wallén's work include Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Extracellular vesicles in disease (18 papers). Håkan Wallén is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Extracellular vesicles in disease (18 papers). Håkan Wallén collaborates with scholars based in Sweden, United States and United Kingdom. Håkan Wallén's co-authors include Fariborz Mobarrez, Charlotte Thålin, Margareta Blombäck, Sebastian Lundström, Nigel Mackman, Yohei Hisada, Peter Henriksson, Gun Jörneskog, Bo‐Michael Bellander and Michael Nekludov and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

Håkan Wallén

128 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil Extracellular Traps

2019 292 citations Charlotte Thålin, Sebastian Lundström et al. profile →

Peers

Countries citing papers authored by Håkan Wallén

Since Specialization

Citations

This map shows the geographic impact of Håkan Wallén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkan Wallén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkan Wallén more than expected).

Fields of papers citing papers by Håkan Wallén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Håkan Wallén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkan Wallén. The network helps show where Håkan Wallén may publish in the future.

Co-authorship network of co-authors of Håkan Wallén

This figure shows the co-authorship network connecting the top 25 collaborators of Håkan Wallén. A scholar is included among the top collaborators of Håkan Wallén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkan Wallén. Håkan Wallén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function 2024 ·Clinical Kidney Journal ·(unknown), (unknown), Marie Evans, (unknown), Håkan Wallén, Tomas Jernberg, Thomas Kahan, Pia Lundman, Per Tornvall, David Erlinge, Bertil Lindahl, Tomasz Baron, Melinda Rezeli, Jonas Spaak, Stefan H. Jacobson	2
2	COVID-19: Not a thrombotic disease but a thromboinflammatory disease 2024 ·Upsala Journal of Medical Sciences ·Shu He, Margareta Blombäck, Håkan Wallén	2
3	Use of heated tobacco products (IQOS) causes an acute increase in arterial stiffness and platelet thrombus formation 2023 ·Atherosclerosis ·(unknown), (unknown), (unknown), (unknown), Lukasz Antoniewicz, Anders Blomberg, Håkan Wallén, Jenny A. Bosson, Linnéa Hedman, Sara Tehrani, Magnus Lundbäck	16
4	Worse long term prognosis in new onset HFpEF treated in HF clinics compared to HFrEF and HFmrEF patients; reflecting need for effective treatment in HFpEF. Results from the Stockholm PREFERS Study 2023 ·European Heart Journal ·Mattias Ekström, Camilla Hage, Patrik Lyngå, (unknown), Bengt Persson, Maria J. Eriksson, Håkan Wallén, Cecilia Linde, Hans Persson	1
5	Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism 2023 ·Journal of Thrombosis and Haemostasis ·Axel Rosell, (unknown), (unknown), Henry Ng, (unknown), (unknown), Sebastian Lundström, Nigel Mackman, Håkan Wallén, Eli Westerlund, Charlotte Thålin	12
6	Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death 2022 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Nicola Orsini, Karin Modig, Håkan Wallén, Bruna Gigante	0
7	Perivascular Macrophages Regulate Blood Flow Following Tissue Damage 2021 ·Circulation Research ·Evelina Vågesjö, (unknown), David Ahl, Cédric Seignez, Carmen Herrera Hidalgo, Antoine Giraud, (unknown), Olle Korsgren, Håkan Wallén, (unknown), Harri Hakovirta, Helene Rundqvist, Magnus Essand, Lena Holm, Randall S. Johnson, Charlotte Thålin, Petra Korpisalo, Gustaf Christoffersson, Mia Phillipson	20
8	Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction 2020 ·Journal of Internal Medicine ·Robert Edfors, Lars Lindhagen, Jonas Spaak, Marie Evans, Pontus Andell, Tomasz Baron, (unknown), Melinda Rezeli, (unknown), Pia Lundman, Karolina Szummer, Per Tornvall, Håkan Wallén, Stefan H. Jacobson, Thomas Kahan, György Marko‐Varga, David Erlinge, Stefan James, Bertil Lindahl, Tomas Jernberg	8
9	High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications 2020 ·Thrombosis Research ·(unknown), Fariborz Mobarrez, Gun Jörneskog, Håkan Wallén, Sara Tehrani	11
10	Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden 2020 ·Trials ·Erik Lundström, Eva Isaksson, Per Näsman, Per Wester, Björn Mårtensson, Bo Norrving, Håkan Wallén, Jörgen Borg, Martin Dennis, Gillian Mead, Graeme J. Hankey, Maree L. Hackett, Katharina S. Sunnerhagen	4
11	Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention 2018 ·Thrombosis Research ·Dimitrios Venetsanos, Tomas Lindahl, Sofia Sederholm Lawesson, Kerstin M. Gustafsson, Håkan Wallén, David Erlinge, Eva Swahn, Joakim Alfredsson	3
12	Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer 2018 ·PLoS ONE ·Charlotte Thålin, Sebastian Lundström, Cédric Seignez, Maud Daleskog, Annika Lundström, Peter Henriksson, Thomas Helleday, Mia Phillipson, Håkan Wallén, Mélanie Demers	173
13	Rationale and Design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm Heart Failure Study: An Epidemiological Regional Study in Stockholm County of 2.1 Million Inhabitants 2016 ·European Journal of Heart Failure ·Cecilia Linde, Maria J. Eriksson, Camilla Hage, Håkan Wallén, Bengt Persson, Matthias Corbascio, Joakim Lundeberg, Eva Maret, Martin Ugander, Hans Persson	20
14	NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation 2016 ·Thrombosis Research ·Charlotte Thålin, Mélanie Demers, Bo Blomgren, Siu Ling Wong, Magnus von Arbin, Anders von Heijne, Ann Charlotte Laska, Håkan Wallén, Denisa D. Wagner, Sara Aspberg	145
15	Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal Study 2016 ·PLoS ONE ·(unknown), Marie Åsberg, Åke Nygren, Robert Szulkin, Håkan Wallén, Fariborz Mobarrez, Anna Nager	15
16	Clopidogrel Resistance after Minor Ischemic Stroke or Transient Ischemic Attack is Associated with Radiological Cerebral Small-Vessel Disease 2015 ·Journal of Stroke and Cerebrovascular Diseases ·Annika Lundström, Håkan Wallén, Magnus von Arbin, Gun Jörneskog, Bruna Gigante, Karin Dembrower, Evaldas Laurenčikas, Ann Charlotte Laska	9
17	Platelet-derived microparticles during and after acute coronary syndrome 2012 ·Thrombosis and Haemostasis ·Mika Skeppholm, Fariborz Mobarrez, Karin Malmqvist, Håkan Wallén	59
18	Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate* 2011 ·British Journal of Haematology ·Margareta Blombäck, Shu He, Niklas Bark, Håkan Wallén, Margareta Elg	53
19	ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus 2009 ·Blood Coagulation & Fibrinolysis ·Mika Skeppholm, Anders Kallner, Majid Kalani, Gun Jörneskog, Margareta Blombäck, Håkan Wallén	15
20	Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications 2003 ·Blood Coagulation & Fibrinolysis ·Jovan P. Antović, Marianne Yngen, (unknown), Aleksandra Antovič, Håkan Wallén, Gun Jörneskog, Margareta Blombäck	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact